[Value of Spasmenzyme in gastroenterology].
D002480:Cellulase / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003685:Dehydrocholic Acid / Q000009:adverse effects / Q000627:therapeutic use; D004129:Dimethylpolysiloxanes / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D006867:Hydrolases / Q000627:therapeutic use*; D010194:Pancreatin / Q000009:adverse effects / Q000627:therapeutic use; D010434:Pepsin A / Q000009:adverse effects / Q000627:therapeutic use; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D012828:Silicones / Q000627:therapeutic use*; D013892:Thioxanthenes / Q000009:adverse effects / Q000627:therapeutic use*
D004129:Dimethylpolysiloxanes; D004338:Drug Combinations; D010880:Piperidines; D010919:Placebos; D012828:Silicones; D013892:Thioxanthenes; D010194:Pancreatin; D006867:Hydrolases; D002480:Cellulase; D010434:Pepsin A; D003685:Dehydrocholic Acid
Intérêt du Spasmenzyme en gastroentérologie